Follicle-stimulating hormone is involved in the lipodystrophy of adipose tissue; this involvement is further supported by the ability of FSH to alter the levels of two key indicators of lipid droplet formation, namely leptin and ADPN. Here, BRD2 is linked to lipodystrophy.